Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural Insights into Cdk5 activation by a neuronal Cdk5 activator.

H Y Lim1, K T Seow, Q Li

  • 1The Proteomics Group, Institute of Molecular and Cell Biology, 30 Medical Drive, 117609, Singapore.

Biochemical and Biophysical Research Communications
|July 5, 2001
PubMed
Summary

Cyclin-dependent kinase 5 (Cdk5) is activated by neuronal proteins p35/p25 in a unique phosphorylation-independent manner. Structural modeling suggests an "opened" conformation is key to Cdk5/p25 activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study.

ESMO gastrointestinal oncology·2026
Same author

Distinguishing features of COVID-19 and non-COVID-19 febrile seizures in hospitalised children.

The Medical journal of Malaysia·2024
Same author

Plasma NOTCH3 and the risk of cardiovascular recurrence in patients with ischemic stroke.

QJM : monthly journal of the Association of Physicians·2024
Same author

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Area of Science:

  • Biochemistry
  • Structural Biology
  • Neuroscience

Background:

  • Cyclin-dependent kinase 5 (Cdk5) shares high sequence identity with Cdk1 and Cdk2.
  • Cdk5 is uniquely activated by neuronal activators p35/p25(nck5a) and p39(nck5ai) independently of phosphorylation.
  • Understanding Cdk5 activation is crucial for its role in neuronal development and function.

Purpose of the Study:

  • To elucidate the structural basis for the phosphorylation-independent activation of Cdk5 by its activator p25(nck5a).
  • To compare distinct conformational states of the Cdk5/p25 complex.

Main Methods:

  • Molecular modeling of the Cdk5/p25(nck5a) complex based on X-ray structures of Cdk2/cyclin A.
  • Comparative analysis of obstructed and opened conformational models.

Related Experiment Videos

  • Mutagenesis studies of the p25(nck5a) activator.

    • Main Results:

    • Two models for Cdk5/p25(nck5a) were proposed: an obstructed and an opened conformation.
    • Analysis suggested the opened conformation more accurately represents the active Cdk5/p25(nck5a) structure.
    • Mutagenesis data supported the proposed structural model.

    Conclusions:

    • The findings provide a structural rationale for the unique phosphorylation-independent activation mechanism of Cdk5/p25(nck5a).
    • This study advances the understanding of Cdk5 regulation and its implications in neurological processes.